BHPI and Estrogen Receptor (image) University of Illinois at Urbana-Champaign Share Print E-Mail Caption An experimental drug, BHPI, binds to the estrogen receptor and disrupts the growth of cancer cells. Credit Neal Andruska Usage Restrictions Image may be used only to illustrate stories about the research described in this release. Credit required: Neal Andruska Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.